About Farcast Biosciences India Private Limited
Data last updated:
Farcast Biosciences India Private Limited is a foreign private limited company based in Bangalore, Karnataka, India, a subsidiary of Farcast Biosciences Llc. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 18 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2016FTC093387. Its GSTIN is 29AAKCM3320J1ZC (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹31 Cr and a paid-up capital of ₹31 Cr. It was formerly known as Mitra Rxdx India Private Limited. It is led by directors Satish Sankaran and Mohit Malhotra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2022, the company reported a revenue of ₹6.66 Cr, a growth of 102% compared to the previous year. For the same year it recorded a net loss of ₹1.01 Cr (net margin -15.1%) and EBITDA of -₹81.61 Lakh (EBITDA margin -12.2%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 34% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Farcast Biosciences. The company has 5 deals on record (4 rights issues, 1 funding round), with disclosed funding of ₹26.56 Cr; the latest was in March 2020.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website farcastbio.com.
Company details
Contact details
Farcast Biosciences India Private Limited's registered office is in Bangalore, Karnataka. Its website is farcastbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSalarpuria Symphony Sy No. 8/2 Ground Floor Beratena Agrahara Begur Hobli Hosur Ro, Ad, Bangalore, Karnataka, India – 560100
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
To see the full contact details of Farcast Biosciences India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Farcast Biosciences India operates one associated brand: Farcast Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A system for preserving the tumor microenvironment is developed. | farcastbio.com |
Financials of Farcast Biosciences India Private Limited
FY 2025 filings availableFarcast Biosciences India Private Limited reported revenue of ₹6.66 Cr (up 102% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 102% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹6.66 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹81.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.2% | ||||
| Net Profit Margin | -15.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Farcast Biosciences India Private Limited, buy the company report.
Board of directors of Farcast Biosciences India Private Limited
Farcast Biosciences India has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Sankaran | Director | 30 May 2020 | 6 Years 4 Months | Current |
| Mohit Malhotra | Director | 28 May 2020 | 6 Years 4 Months | Current |
Auditor
Farcast Biosciences India Private Limited is audited by GANAPATH RAJ & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GANAPATH RAJ & CO. | FY 2022 | 000846S |
Shareholding
The shareholding of Farcast Biosciences India Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Farcast Biosciences India Private Limited, buy the company report.
Deals & funding
Farcast Biosciences India Private Limited has 5 deals on record (4 rights issues, 1 funding round), with disclosed funding of ₹26.56 Cr; the latest was in March 2020.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Rights issue | ₹2.19 Cr | Investors: Farcast Biosciences Inc. |
| Aug 2019 | Rights issue | ₹35.52 Cr | Investors: Farcast Biosciences Inc. |
| May 2018 | Rights issue | ₹24.24 Cr | Investors: Farcast Biosciences Inc. |
| Jul 2017 | Rights issue | ₹19.19 Cr | Investors: Farcast Biosciences Inc. |
| Nov 2016 | Funding round | ₹26.56 Cr | Investors: Farcast Biosciences Inc. |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Farcast Biosciences India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Farcast Biosciences India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Farcast Biosciences India Private Limited has a workforce of 30 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Farcast Biosciences India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAKCM3320J1ZC | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Farcast Biosciences India Private Limited, buy the company report.
Recent activity
Farcast Biosciences India Private Limited has 9 board changes on record since 2017: 2 appointments and 7 cessations. The latest: Mohit Malhotra ceased to be Additional Director on 17 Nov 2020.
News
Frequently asked questions
Farcast Biosciences India is an active foreign private limited company based in Bangalore, Karnataka, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 18 May 2016 (10+ years old) and is registered under CIN U73100KA2016FTC093387.
Farcast Biosciences India has 2 current directors:
- Satish Sankaran - Director
- Mohit Malhotra - Director
The latest financial statements of Farcast Biosciences India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Farcast Biosciences India is 29AAKCM3320J1ZC, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Farcast Biosciences India is U73100KA2016FTC093387. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Farcast Biosciences India was incorporated on 18 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Farcast Biosciences India has 5 deals on record (4 rights issues, 1 funding round), with disclosed funding of ₹26.56 Cr; the latest was in March 2020.
Mohit Malhotra ceased to be Additional Director on 17 Nov 2020. Satish Sankaran ceased to be Additional Director on 17 Nov 2020. Satish Sankaran was appointed as Director on 30 May 2020. Farcast Biosciences India has 9 board changes on record in total.
Farcast Biosciences India can be reached through the website farcastbio.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Farcast Biosciences India is at Salarpuria Symphony Sy No. 82 Ground Floor Beratena Agrahara Begur Hobli Hosur Ro, Ad, Bangalore, Karnataka, India – 560100.